FBT:LSE:LSE-First Trust Global Funds Plc - First Trust Nyse Arca Biotechnology Index Ucits ETF (GBX)

ETF | Others |

Last Closing

USD 1564.8

Change

0.00 (0.00)%

Market Cap

USD 7.86M

Volume

2.48K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 572.76B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 572.76B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B
0QZ3:LSE Qualcomm Inc.

N/A

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 200.79B
0R24:LSE Intel Corp.

N/A

USD 196.14B

ETFs Containing FBT:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.54% 31% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.54% 31% F 40% F
Trailing 12 Months  
Capital Gain 6.40% 28% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.40% 28% F 37% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.78% N/A N/A 40% F
Dividend Return 0.78% N/A N/A 39% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.82% N/A N/A 86% B+
Risk Adjusted Return 9.95% N/A N/A 46% F
Market Capitalization 7.86M 22% F 12% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.